Provider QP58-19 Pharmacy Benefit Exclusion for Zolgensma (onasemnogene abeparvovec-xioi) Injection Read More
Provider QP56-19 Pharmacy Benefit Update – New Drug-Related Step Therapy Criteria: Topical Corticosteroids Read More
Provider QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs Read More
Provider QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy Read More
Provider QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis Read More
Provider QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG) Read More
Provider QP54-19 Pharmacy Benefit Update – New Drug-Related Utilization Management Program: Opioid Immediate Release (IR) New to Therapy (NTT) Program Read More
Provider QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga Read More
Provider QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis Read More
